SCHEMBL21915917

SCHEMBL21915917

CCSNc1ncc(CC)c(-c2cc(C)c(=O)n(C)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 18/20 0.39
CREBBP Q92793 2/20 0.37
BRD9 Q9H8M2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16650976 0.82 BRD4 (0.51) BRD4CREBBP
SCHEMBL19930968 0.81 EGFR (0.41) BRD4CREBBPBRD9
SCHEMBL19930955 0.81 CREBBP (0.36) BRD4CREBBP
SCHEMBL19930818 0.79 CREBBP (0.35) BRD4CREBBPBRD9
SCHEMBL19930864 0.76 BRD4 (0.43) BRD4BRD9
SCHEMBL16652035 0.75 BRD4 (0.58) BRD4CREBBPBRD9
SCHEMBL29848794 0.75 BRD4 (0.58) BRD4CREBBPBRD9
SCHEMBL16651476 0.75 CREBBP (0.48) BRD4CREBBP
SCHEMBL25043398 0.74 BRD4 (0.40) BRD4CREBBP
SCHEMBL16650869 0.73 CREBBP (0.47) BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4134364-A2 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2023-02-15 EP disclosed
EP-3640241-A1 BROMODOMAIN INHIBITORS Celgene Quanticel Research, Inc. (US) 2020-04-22 EP disclosed